Bummer! Sales have ended.
Unfortunately, tickets for this event are no longer on sale.
The current innovation system that relies on high prices to recoup R&D costs is failing many people affected by HIV/AIDS and TB in developing countries. The true extent of the innovation and access crisis is only just starting to become apparent as access to newer health technologies is being restricted. Although a large number of important medicines, diagnostics, and other technologies are available or in the pipeline, there are numerous critical gaps that illustrate how today’s R&D system is not delivering for the poorest.
This satellite will present the challenges but also promising initiatives that could facilitate the development of affordable medical tools adapted to the needs of patients in resource-limited settings. The session will explore the relevance for HIV/AIDS & TB of recent recommendations from the WHO’s Consultative Expert Working Group on R&D Financing and Coordination, including a binding global R&D convention.